Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

LAVI.AT

HOLD

Lavipharm S.A. · Healthcare · Greece · $309M · Avg Vol: $303K/d

59
StockRank
Q
58
V
21
M
69
P/E (TTM)
51.9x
ROE
10.6%
D/E
0.6x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
Loading...
PRICE (1M)-8.9%
1.781.831.881.931.98May 7May 28Jun 18
SMA 50SMA 200
Close
$1.78
RSI (14)
14.4
52W High
$2.02
From 52W High
0.9%

SCORE BREAKDOWN

Quality
58
ROIC
10.8%75.7
ROE
10.6%73.5
GP/Assets
23.7%54.2
Op. Margin
12.5%70.7
FCF/Assets
1.6%55.9
Piotroski
—83.4
Int. Cover
5.1x55.1
D/E Ratio
0.58x28.2
Current Ratio
1.21x16.0
Value
21
P/E (TTM)
51.9x19.4
EV/EBITDA
21.8x16.5
P/FCF
111.8x9.1
P/B
4.7x26.0
P/S
4.1x46.4
Div Yield
—N/A
Momentum
69
52W High %
88%85.9
RS 6M
69%95.5
SMA 50/200
1.37x96.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-50%10.4

FUNDAMENTALS

Market Cap
$309M
P/E (Forward)
—
Gross Margin
47.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LAVI.AT are excluded.

TickerCompanyMkt CapStockRankSignal
LAVI.ATLavipharm S.A.(you)$309M59HOLD
IATR.ATAthens Medical C.S.A.$178M24SELL

Peer medians: ROE -4.1% · Gross margin 19.9%

Lavipharm S.A. (LAVI.AT) — Stock Score Summary

Lavipharm S.A. (LAVI.AT) has a MoatMap StockRank of 59/100 based on Quality (58/100), Value (21/100), and Momentum (69/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price$1.78
Market Cap$309M
P/E (TTM)51.87
Price/Book4.66
Return on Equity10.6%
Return on Invested Capital10.8%
Debt/Equity58.10
Gross Margin47.8%
Operating Margin12.5%
Revenue Growth15.4%
Free Cash Flow$3M

Lavipharm S.A. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Greece).

Frequently Asked Questions

What is Lavipharm S.A.’s (LAVI.AT) StockRank?
MoatMap’s StockRank for Lavipharm S.A. (LAVI.AT) is 59/100, with a Hold signal. It is a composite of Quality (58), Value (21), and Momentum (69) factor ranks across MoatMap’s 20,000+ stock universe.
Does Lavipharm S.A. have an economic moat?
Lavipharm S.A. (LAVI.AT) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Lavipharm S.A. a buy, hold, or sell?
MoatMap’s current signal for Lavipharm S.A. (LAVI.AT) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Lavipharm S.A. in?
Lavipharm S.A. (LAVI.AT) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Greece).
Browse all ranked stocksLAVI.AT deep dive reportAI ChampionsHow we score stocksSense-check another stock